CERO

CERo Therapeutics Holdings, Inc.

OTCHealthcareBiotechnologyUS

USD0.01

+0.00 (+6.34%)

Rating:B-

Company Profile

CEO

Christopher Ehrlich

IPO Date

2021-11-30

Sector

Healthcare

Industry

Biotechnology

Exchange

OTC

Country

Market Metrics

Open

$0.01

Prev. Close

$0.01

Day Low

$0.01

Day High

$0.01

52W Low

$0.01

52W High

$8.90

Market Cap

$0.00B

Volume

0.21M

Price Chart

+33.33% over 1M

About

CERo Therapeutics Holdings, Inc. is a biotech firm dedicated to pioneering advanced engineered T-cell immunotherapies for the treatment of various cancers. Their leading therapeutic candidate, CER-1236, is an autologous T-cell therapy currently in development, aimed at addressing both blood cancers (hematologic malignancies) and solid tumors. This company was founded in 2021 and is headquartered in South San Francisco, California.

https://www.cero.bio

Price Performance

1 Day

+6.34%

5 Days

-3.61%

1 Month

+33.33%

3 Months